• HUB Cyber Security acquired senior subordinated convertible notes and purchase rights of Evofem Biosciences in a zero-cash, all-equity exchange.
• Transaction issued ordinary shares and/or pre-funded warrants to certain Evofem noteholders, preserving HUB’s cash position.
• Deal extends HUB’s balance sheet turnaround, including sharp cost cuts and a roughly 50% reduction in HUB-level headcount.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HUB Cyber Security Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607010700PRIMZONEFULLFEED9755508) on July 01, 2026, and is solely responsible for the information contained therein.